Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia
Clinical trial NCT01266876 · COMPLETED
Trial details
- NCT number
- NCT01266876
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-11-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.